Patents
Patents for C07K 19 - Hybrid peptides (29,428)
02/2008
02/12/2008CA2387018C Chemokine receptor
02/12/2008CA2190802C A method of preparing and recovering proteins
02/07/2008WO2008016314A1 Myostatin antagonists
02/07/2008WO2008015841A1 Kinase-inhibiting fused protein and pharmaceutical composition
02/07/2008WO2008015480A2 Composition and method for modulating an immune response
02/07/2008WO2008015425A2 Mhc oligomers, components thereof, and methods of making the same
02/07/2008WO2008014612A1 Fusion proteins and methods for modulation of immune response
02/07/2008WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
02/07/2008US20080032342 Chimeric immunogens
02/07/2008CA2693378A1 Myostatin antagonists
02/07/2008CA2693326A1 Gm-csf and il-15 fusokines and methods for modulation of the immune response
02/07/2008CA2555137A1 Puroindolines as fusion-protein carriers in molecular pharming
02/06/2008EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation
02/06/2008CN101117635A Fusion expression of PTD,HIF ODD and tumour inhibitory gene and uses thereof
02/06/2008CN100366746C Novel alkaline protease from bacillius sp. (DSM 14390) and washing and cleaning products comprising said novel alkaline protease
02/05/2008US7326566 Compositions and methods for screening antimicrobials
02/05/2008US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof
02/05/2008US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis
02/05/2008US7326530 Method for localizing polypeptide on cell surface
02/01/2008WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES
02/01/2008CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes
01/2008
01/31/2008WO2008012629A2 Exendin fusion proteins
01/31/2008WO2008011672A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide
01/31/2008WO2006134190A8 Agents and methods based on the use of the eda domain of fibronectin
01/31/2008US20080027213 Chimeric immunogens
01/31/2008US20080026985 Control of gene expression
01/31/2008US20080026404 G-protein coupled receptor for use in identifying modulators of taste perception in mammals; improving the palatability of low-calorie beverages
01/31/2008US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
01/31/2008US20080025983 Methods of screening based on the EGF receptor crystal structure
01/31/2008DE102006034319A1 Chirale mit Phosponsäurester- oder Phosphonsäure- substituierte Verbindungen Chiral with Phosponsäurester- or phosphonic acid substituted compounds
01/31/2008CA2658654A1 Exendin fusion proteins
01/30/2008EP1882700A1 Biotinylated MHC complexes and their uses
01/30/2008EP1882478A1 Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
01/30/2008CN101115771A 人类抗体和蛋白质 Human antibodies and proteins
01/30/2008CN101113179A Human antibody sample molecule TEM8-Fc based on tumour endocytosis sign 8 and its application in tumour treatment
01/30/2008CN101113178A Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (CTL) epitopes
01/30/2008CN100365120C Compounds and methods for treatment and diagnosis of chlamydial infection
01/30/2008CN100365022C Fusion toxin protein and uses thereof
01/29/2008US7323549 IL-7 fusion proteins
01/29/2008US7323440 De-immunized MOG (poly)peptide constructs
01/29/2008US7323175 Immunogenicity of glucan binding protein
01/28/2008CA2595306A1 Recombinant antibodies to sclerotinia antigens
01/24/2008WO2008009727A1 Positive cytomodulines to improve bioreactor productivity.
01/24/2008WO2007137760A3 Dimeric molecular complexes
01/24/2008US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
01/24/2008US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
01/24/2008CA2661310A1 Process for preparing hybrid proteins
01/24/2008CA2658683A1 Positive cytomodulines to improve bioreactor productivity
01/24/2008CA2658286A1 Human glp-1 mimetibodies, compositions, methods and uses
01/24/2008CA2657934A1 Wsx-1/p28 as a target for anti-inflammatory responses
01/23/2008EP1504368A4 Method for crystallizing human gsk3 and novel crystal structure thereof
01/23/2008EP1446478B1 Dimerized growth factor and materials and methods for producing it
01/23/2008EP1436316B1 Subcellular targeting of therapeutic proteins
01/23/2008EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease
01/23/2008EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof
01/23/2008EP1210372B1 Human monoclonal antibodies to her2/neu
01/23/2008EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof
01/23/2008CN101111595A Method of constructing novel higher plant and mehtod of promoting the growth of higher plant
01/23/2008CN101111522A Plad domain peptides with increased serum half life due to conjugation to domain antibodies
01/23/2008CN101108882A Fusion protein of HIV regulatory/accessory proteins
01/22/2008US7320787 Genetic engineering; desroying infections; antitumor, anticancer agents
01/22/2008CA2380569C Chimeric polypeptides, method for production and uses thereof
01/17/2008WO2008006458A2 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them
01/17/2008US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof
01/17/2008US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV
01/17/2008US20080014208 Fusion proteins, uses thereof and processes for producing same
01/17/2008DE102005028545A1 New Cherkasky fusion protein comprises antibody binding protein, non-antibody binding domain and/or any domain useful as materials, medicines, coloring- and labelling materials, adhesives and diagnostic systems
01/16/2008EP1878751A2 Single domain - Fc fusion constructs
01/16/2008EP1878750A2 Single domain - Fc fusion constructs
01/16/2008EP1878744A1 Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
01/16/2008EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b
01/16/2008EP1878438A2 Ligand/llytic peptide compositions and methods of use
01/16/2008EP1613644A4 Peg-physiologically active polypeptide homodimer complex having prolonged in vivo half-life and process for the preparation thereof
01/16/2008CN101104641A Fusion protein of PRRS virus used as swine procreation and respiratory tract syndrome vaccine
01/16/2008CN100362020C Recombinant fusion protein of fibroin and RGD, and its biological synthesis method
01/16/2008CN100361708C Fusion protein for stimulating organism to produce FMDV antibody and its coding gene and uses
01/15/2008US7319144 Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay
01/15/2008US7319137 PRO1339 polypeptides
01/15/2008US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
01/15/2008CA2090549C Bacterial surface protein expression
01/10/2008WO2008003103A2 Novel multivalent immunoglobulins
01/10/2008WO2007091178A3 Construction of new variants of dextransucrase dsr-s by genetic engineering
01/10/2008WO2005061534A3 Improved tuberculosis vaccines
01/10/2008US20080009604 Novel polypeptide and process for producing the same
01/10/2008US20080009446 Recombinant human albumin fusion proteins with long-lasting biological effects
01/10/2008US20080009025 Protein kinase regulation
01/10/2008CA2667974A1 Chimeric zinc finger recombinases optimized for catalysis by directed evolution
01/09/2008EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
01/09/2008EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
01/09/2008EP0917581B1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
01/09/2008CN101103045A 修饰的Fc分子 Modified Fc molecule
01/09/2008CN101100673A Mycobacterium tuberculosis recombination fusion protein and application thereof
01/09/2008CN101100672A Modified HPV E6-E7 fusion gene and coding protein thereof
01/09/2008CN101100671A Human anti-HBsAg single-chain antibody/human antibody light chain constant region/protamine truncated recombination gene, coding protein and application
01/09/2008CN101100487A Fusion protein capable of removing HPV E7 protein and its encoding gene and application
01/09/2008CN100360556C Hepatitis B core antigen fusion proteins
01/08/2008US7317080 PRO4303 polypeptides
01/08/2008CA2335079C Composition for the treatement of immune deficiencies and methods for its preparation and use
01/08/2008CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
01/04/2008CA2591804A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases